Answers are grounded in this paper and cite their sources.
Assessment of GLP-1s shows potential benefits for obesity treatment in youth, suggesting further investigation is needed.
The Brown University Child & Adolescent Psychopharmacology UpdateVolume 27, Issue 9 p. 7 Research briefs Should GLP-1s be used to treat youth obesity? Alison Knopf, Alison KnopfSearch for more papers by this author Alison Knopf, Alison KnopfSearch for more papers by this author First published: 25 August 2025 https://doi.org/10.1002/cpu.31004Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookxLinkedInRedditWechatBluesky No abstract is available for this article. Volume27, Issue9September 2025Page 7 RelatedInformation
No takes yet. Share an insight, caveat, or question.
Alison Knopf (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: